stockrowMedtronic PLC
MDT Healthcare Medical Devices
Medtronic PLC’s revenue for fiscal 2026 (year ended April 2026) was $36.4 billion, up 8.43% from fiscal 2025.
- Revenue
- +13.7%
- EPS
- +42.0%
- Free cash flow
- +120.9%
- Total debt
- −1.59%
Quarter to July 2026, against a year earlier
Follow MDT
Alert me
Medtronic PLC (MDT) Return on assets
Medtronic PLC's return on assets over the twelve months to 31 July 2026 was 5.68%, up 0.5 percentage points from fiscal 2026 (5.20%). Over the past ten years it has ranged from 3.25% (fiscal 2018) to 5.48% (fiscal 2022); the current reading is higher than 83% of that period. That is above the Medical Devices industry median of −17.3% and above the Healthcare sector median of −29.3%.
Return on assets, annual
Embed this chart
Annual newest first
| Period | Return on assets | Change (points) |
|---|---|---|
| FY2026 | 5.20% | 0.07 |
| FY2025 | 5.13% | 1.07 |
| FY2024 | 4.06% | (0.07) |
| FY2023 | 4.13% | (1.35) |
| FY2022 | 5.48% | 1.56 |
| FY2021 | 3.92% | (1.39) |
| FY2020 | 5.31% | 0.20 |
| FY2019 | 5.11% | 1.86 |
| FY2018 | 3.25% | (0.79) |
| FY2017 | 4.04% | 0.61 |
Against its own ten years
Return on assets against peers
| Company | Return on assets |
|---|---|
| DXCM DexCom, Inc. compare | 14.4% |
| BSX Boston Scientific Corporation compare | 7.94% |
| STE STERIS plc compare | 7.83% |
| SYK Stryker Corporation compare | 7.68% |
| EW Edwards Lifesciences Corporation compare | 7.45% |
| GEHC GE HealthCare Technologies Inc. compare | 5.78% |
| MDT Medtronic PLC | 5.68% |
| PHG Koninklijke Philips N.V. compare | 3.49% |
| ABT Abbott Laboratories compare | 0.00% |
| Medical Devices industry median | −17.3% |
| Healthcare sector median | −29.3% |
| Market median | 0.00% |
What Return on assets is
ROA tells an investor how much profit a company earns for shareholders from the assets it uses to run its business.
Annual: Net Income Allotted to Shareholders ÷ Average Assets; TTM: Net Income Allotted to Shareholders ÷ Average Assets (latest quarter)
More on MDT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement